7-55174015-G-C

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate

The NM_005228.5(EGFR):​c.2156G>C​(p.Gly719Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G719C) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 33)

Consequence

EGFR
NM_005228.5 missense

Scores

13
5
1

Clinical Significance

Pathogenic criteria provided, single submitter P:5

Conservation

PhyloP100: 9.90
Variant links:
Genes affected
EGFR (HGNC:3236): (epidermal growth factor receptor) The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM1
In a binding_site (size 8) in uniprot entity EGFR_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_005228.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr7-55174014-G-T is described in ClinVar as [Likely_pathogenic, drug_response]. Clinvar id is 16611.Status of the report is no_assertion_criteria_provided, 0 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.993
PP5
Variant 7-55174015-G-C is Pathogenic according to our data. Variant chr7-55174015-G-C is described in ClinVar as [Pathogenic]. Clinvar id is 45225.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
EGFRNM_005228.5 linkuse as main transcriptc.2156G>C p.Gly719Ala missense_variant 18/28 ENST00000275493.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
EGFRENST00000275493.7 linkuse as main transcriptc.2156G>C p.Gly719Ala missense_variant 18/281 NM_005228.5 P1P00533-1
EGFRENST00000455089.5 linkuse as main transcriptc.2021G>C p.Gly674Ala missense_variant 17/261
EGFRENST00000450046.2 linkuse as main transcriptc.1997G>C p.Gly666Ala missense_variant 18/284
EGFRENST00000700145.1 linkuse as main transcriptc.506G>C p.Gly169Ala missense_variant 5/9

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Non-small cell lung carcinoma Pathogenic:3
Pathogenic, no assertion criteria providedliterature onlyDatabase of Curated Mutations (DoCM)Jul 14, 2015- -
Pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 04, 2013The Gly719Ala variant has been reported in isolation in individuals with increased sensitivity to gefitinib treatment (Han 2005). -
Pathogenic, no assertion criteria providedcurationMolecular Diagnostics Laboratory, University of Rochester Medical Center-- -
Glioblastoma Pathogenic:1
Likely pathogenic, no assertion criteria providedliterature onlyDatabase of Curated Mutations (DoCM)May 31, 2016- -
Lung adenocarcinoma Pathogenic:1
Likely pathogenic, no assertion criteria providedliterature onlyDatabase of Curated Mutations (DoCM)May 31, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.41
D
BayesDel_noAF
Pathogenic
0.35
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.75
D;D;D
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
1.0
D;D;D
M_CAP
Pathogenic
0.39
D
MetaRNN
Pathogenic
0.99
D;D;D
MetaSVM
Uncertain
0.57
D
MutationAssessor
Pathogenic
3.0
.;.;M
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Pathogenic
0.85
D
PROVEAN
Pathogenic
-5.1
D;.;D
REVEL
Pathogenic
0.82
Sift
Uncertain
0.0020
D;.;D
Sift4G
Uncertain
0.0040
D;D;D
Polyphen
1.0
D;.;D
Vest4
0.96
MutPred
0.94
.;.;Loss of sheet (P = 0.0817);
MVP
0.95
MPC
1.4
ClinPred
0.99
D
GERP RS
5.5
Varity_R
0.96
gMVP
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121913428; hg19: chr7-55241708; COSMIC: COSV51769339; COSMIC: COSV51769339; API